Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDEGENE LTD. Plunges 7%; BSE HEALTHCARE Index Down 1.1%
Tue, 29 Oct 10:10

INDEGENE LTD. Plunges 7%; BSE HEALTHCARE Index Down 1.1%Image source: Sefa Ozel/www.istockphoto.com

INDEGENE LTD. share price has plunged 7% and is presently trading at Rs 644.6.

Meanwhile, the BSE HEALTHCARE index is at 42,936.0 (down 1.1%).

Among the top losers in the BSE HEALTHCARE index today are POLY MEDICURE (down 4.5%) and Cipla (down 3.0%).

MAX HEALTHCARE INSTITUTE (up 1.3%) and CAPLIN POINT (up 1.3%) are among the top gainers today.

Over the last one year, INDEGENE LTD. has moved up from Rs 0.0 to Rs 644.6, registering a gain of Rs 644.6 .

On the other hand, the BSE HEALTHCARE index has moved up from 27,318.2 to 42,936.0, registering a gain of 57.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 228.2%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 118.5%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,634.6 (down 0.5%).

The top losers among the BSE Sensex today are Tata Motors (down 2.8%) and Bharti Airtel (down 2.5%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,209.6 (down 0.5%). Bajaj Auto and Cipla are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,049.1 to 79,634.6, registering a gain of 15,585.6 points (up 24.3%).

INDEGENE LTD. Financial Update...

INDEGENE LTD. net profit fell {profitpercent} YoY to Rs 917 million for the quarter ended September 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 6,868 million during the period as against Rs {salesnumberprev} million in {quarterprev}.

For the year ended March 2024, INDEGENE LTD. reported 26.5% increase in net profit to Rs 3,367 million compared to net profit of Rs 2,661 million during FY23. Revenue of the company grew 12.3% to Rs 25,896 million during FY24.


Equitymaster requests your view! Post a comment on "INDEGENE LTD. Plunges 7%; BSE HEALTHCARE Index Down 1.1%". Click here!